Kunihiro Yoshisue
Tsukuba, 3002611, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications
Construction of physiologically based pharmacokinetic model to predict CYP1A autoinduction by multi-kinase inhibitor TSU-68 based on in vitro induction kinetics.
Journal: Journal of pharmaceutical sciences
Published: May 30, 2025
A semimechanistic population pharmacokinetic and pharmacodynamic model incorporating autoinduction for the dose justification of TAS-114.
Journal: CPT: pharmacometrics & systems pharmacology
Published: June 02, 2021
Pharmacokinetics of S-1 monotherapy in plasma and in tears for gastric cancer patients.
Journal: International journal of clinical oncology
Published: October 10, 2018
TAS-114, a First-in-Class Dual dUTPase/DPD Inhibitor, Demonstrates Potential to Improve Therapeutic Efficacy of Fluoropyrimidine-Based Chemotherapy.
Journal: Molecular cancer therapeutics
Published: September 15, 2017
Contribution of equilibrative nucleoside transporter(s) to intestinal basolateral and apical transports of anticancer trifluridine.
Journal: Biopharmaceutics & drug disposition
Published: May 19, 2017
Phase I clinical and pharmacokinetic study of S-1 plus oral leucovorin in patients with metastatic colorectal cancer.
Journal: Cancer chemotherapy and pharmacology
Published: October 17, 2016
Pharmacokinetics of initial full and subsequent reduced doses of S-1 in patients with locally advanced head and neck cancer-effect of renal insufficiency.
Journal: Japanese journal of clinical oncology
Published: October 12, 2016
Exposure-dependent incorporation of trifluridine into DNA of tumors and white blood cells in tumor-bearing mouse.
Journal: Cancer chemotherapy and pharmacology
Published: May 11, 2015
Involvement of Concentrative Nucleoside Transporter 1 in Intestinal Absorption of Trifluridine Using Human Small Intestinal Epithelial Cells.
Journal: Journal of pharmaceutical sciences
Published: January 30, 2015
Effect of CYP2A6 genetic polymorphism on the metabolic conversion of tegafur to 5-fluorouracil and its enantioselectivity.
Journal: Drug metabolism and disposition: the biological fate of chemicals
Published: July 09, 2014
Species variation in the enantioselective metabolism of tegafur to 5-fluorouracil among rats, dogs and monkeys.
Journal: The Journal of pharmacy and pharmacology
Published: November 26, 2013
Enantioselectivity in the cytochrome P450-dependent conversion of tegafur to 5-fluorouracil in human liver microsomes.
Journal: Pharmacology research & perspectives
Published: August 07, 2013
Last Updated: 09/26/2026